首页 > 市场调查报告书 > 医疗设备

生技设备

市场调查报告书

商品编码

1606542

全球医疗生物感测器市场 - 2024-2031

Global Medical biosensors market - 2024-2031

出版日期: 2024年12月04日 | 出版商:

DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

概述

2023年，全球医疗生物感测器市场规模达到56.5亿美元，预计2031年将达到109亿美元，2024-2031年预测期间复合年增长率为8.5%。

生物感测器是一种分析设备，它结合了感测器系统和感测器等生物检测元件，将生物响应转换为电讯号。它的工作原理是与被测分析物通信，并透过感测器将响应转换为电讯号。医用生物感测器在医疗诊断和患者监测中发挥重要作用，因为它们利用生物分子、组织和生物体，特别适合应对即时检测挑战。葡萄糖生物感测器广泛应用于糖尿病诊断的临床应用，占全球市场的85%。生物感测器领域已扩展到多种类型，包括免疫感测器和热生物感测器。

科技进步的崛起

技术进步透过提高这些设备的精度、功能和可访问性来推动全球医疗生物感测器市场的成长。奈米技术创新提高了生物感测器的灵敏度和特异性，从而实现了早期疾病诊断。人工智慧和机器学习演算法已将生物感测器转变为智慧诊断工具，提供即时资料分析、预测见解和个人化健康建议。

灵活的可穿戴生物感测器已将其应用扩展到临床环境之外，从而实现持续的健康监测和远端患者护理。蓝牙和 NFC 等无线通讯技术实现了生物感测器和数位健康平台之间的无缝连接。微型化和生物相容性材料使生物感测器更加用户友好，使其成为现代医疗系统中不可或缺的工具。

例如，2024 年 10 月，义法半导体推出了一款新型医疗生物感测晶片 ST1VAFE3BX，适用于智慧手錶、运动手环、互联戒指和智慧眼镜等医疗保健穿戴式装置。该晶片采用高精度生物电位输入和惯性感测，确保更快的性能和更低的功耗。。来自 vAFE 的类比讯号与来自加速度感测器的运动资料组合在一个紧凑的封装中，可以进行精确的上下文感知资料分析，直接在感测器上支援人工智慧演算法。

准确性和可靠性限制

儘管生物感测器取得了显着进步，但在不同条件下保持准确性和可靠性的能力始终是一个挑战。这种变化包括环境条件、用户变化和感测器退化。所有这些因素都会影响设备的性能，导致读数误导。在医疗保健应用的关键领域，例如糖尿病管理中的血糖监测，轻微的不准确甚至可能是致命的。如此高品质的性能和可靠性通常需要先进的技术和频繁的校准，这会增加成本和维护要求。因此，许多应用限制了生物感测器在当前市场中的准确性和可靠性的可用性。

A biosensor is an analytical device that combines biological detecting elements like a sensor system and a transducer to convert a biological response into an electrical signal. It works by communicating with the analyte being tested and converting the response into an electrical signal by the transducer. Medical biosensors play a significant role in medical diagnostics and patient monitoring, as they are uniquely suited to real-time detection challenges due to their use of biological molecules, tissues, and organisms. Glucose biosensors are widely used in clinical applications for diabetes diagnosis, accounting for 85% of the world market. The biosensor field has expanded into various types, including immunosensors and thermal biosensors.Market Dynamics: Drivers & Restraints

Rise in the Technological Advancements

Technological advancements are driving the growth of the global medical biosensors market by improving the precision, functionality, and accessibility of these devices. Nanotechnology innovations have enhanced the sensitivity and specificity of biosensors, enabling early disease diagnosis. Artificial intelligence and machine learning algorithms have transformed biosensors into smart diagnostic tools, providing real-time data analysis, predictive insights, and personalized health recommendations.

Flexible and wearable biosensors have expanded their applications beyond clinical settings, enabling continuous health monitoring and remote patient care. Wireless communication technologies like Bluetooth and NFC have enabled seamless connectivity between biosensors and digital health platforms. Miniaturization and biocompatible materials have made biosensors more user-friendly, making them indispensable tools in modern healthcare systems.

For instance, in October 2024, STMicroelectronics has introduced a new medical bio-sensing chip, the ST1VAFE3BX, for healthcare wearables like smart watches, sports bands, connected rings, and smart glasses. The chip uses high-accuracy biopotential input and inertial sensing, ensuring faster performance with lower power consumption.ST's biosensor has enabled the development of precise athlete performance monitoring systems, including ECG analysis in chest bands or small patches. The combination of analog signal from the vAFE with motion data from the acceleration sensor in a compact package allows for precise and context-aware data analysis, supporting AI algorithms directly on the sensor.

Accuracy and Reliability Limitations

Although biosensors have advanced significantly, the ability to maintain accuracy and reliability under varying conditions has always been a challenge. Such variation includes environmental conditions, user variability, and sensor deterioration. All these factors affect the performance of the device and thus lead to misleading readings. In critical areas of healthcare applications, such as glucose monitoring in diabetic management, slight inaccuracies can even be fatal. Such high-quality performance and dependability usually require advanced technology and frequent calibrations, which increase costs and maintenance requirements. With these, many applications restrict the usability of biosensors for accuracy and reliability in the ongoing market.

Segment Analysis

The global medical biosensors market is segmented based on product type, application, technology, end user and region.

Product type:

Wearable Biosensors segment is expected to dominate the medical biosensors market share

The wearable biosensors segment holds a major portion of the medical biosensors market share and is expected to continue to hold a significant portion of the medical biosensors market share during the forecast period.

Wearable biosensors are revolutionizing the medical biosensors market by providing real-time health monitoring and diagnostic capabilities in a non-invasive manner. These devices, such as smartwatches, patches, and fitness bands, measure biomarkers like glucose levels, heart rate, blood pressure, and oxygen saturation. The rise in chronic diseases and demand for personalized medicine has driven the adoption of wearable biosensors. They are also used in remote patient monitoring, telehealth applications, and fitness tracking, especially during the COVID-19 pandemic. Advancements in sensor miniaturization, wireless connectivity, and AI-driven platforms are expected to further enhance the adoption and functionality of wearable biosensors, expanding their role in modern healthcare.

For instance, in June 2024, Trinity Biotech, a biotechnology company specializing in human diagnostics and diabetes management solutions, has launched its continuous glucose monitoring (CGM) microsite. The site will provide stakeholders with insights into the company's vision for the next generation of its CGM biosensor technology and AI-driven health analytics platform, as well as international commercialization of these solutions.

Application:

Diagnostics segment is the fastest-growing segment in medical biosensors market share

The diagnostics segment is the fastest-growing segment in the medical biosensors market share and is expected to hold the market share over the forecast period.

Diagnostics are a crucial segment of the global medical biosensors market, utilizing biosensor technology for accurate, rapid, and sensitive disease detection. These sensors are increasingly used in point-of-care diagnostics for conditions like diabetes, infectious diseases, cancer, and cardiovascular ailments, offering convenience and speed over traditional laboratory methods. They detect specific biological markers through electrochemical, optical, and piezoelectric methods, ensuring high precision and reliability. Advancements in portable and miniaturized biosensors have extended their use into home diagnostics, empowering individuals to self-monitor their health and reducing healthcare facility burden. The growing focus on personalized and preventive medicine and increasing incidence of chronic and infectious diseases highlight the importance of diagnostics in the biosensors market.

Geographical Analysis

North America is expected to hold a significant position in the medical biosensors market share

North America holds a substantial position in the medical biosensors market and is expected to hold most of the market share due to well-established healthcare infrastructure, advanced technological capabilities, and willingness to adopt innovative medical devices. In the U.S., chronic diseases have a higher prevalence, creating enormous opportunities for biosensors in hospitals or home care. Moreover, investments in healthcare research and reimbursement policies promote the exceptional adoption of biosensors for diagnosis and monitoring. Further, the contributions of Canada towards North America's market growth are significant; it is rapidly adopting wearable biosensors in its elderly population.

For instance, in November 2024, A new variant of human mpox has claimed the lives of 5% of people with reported infections in the Democratic Republic of the Congo since 2023, many of them children. The outbreak has spread to several other countries, leading to the World Health Organization declaring it a Public Health Emergency of International Concern. A different, rarely fatal mpox variant has caused an outbreak in over 100 countries since 2022. Researchers from the University of California School of Medicine and Boston University have developed an optical biosensor that can rapidly detect monkeypox, the virus that causes mpox, allowing clinicians to diagnose the disease at the point of care.

Moreover, in November 2023, A Malmo University researcher has developed a wireless biosensor that allows early detection of infections through smart catheters, diapers, or wound dressings. The technology has potential applications in health monitoring and disease monitoring. However, it requires reliable, user-friendly sensors that don't require traditional integrated circuits or bulky batteries.

Europe is growing at the fastest pace in the medical biosensors market

Europe holds the fastest pace in the medical biosensors market and is expected to hold most of the market share due to its robust healthcare infrastructure, increasing prevalence of chronic diseases, and strong government support for innovative medical technologies. The aging population in Europe is driving demand for advanced diagnostic and monitoring devices, particularly wearable devices, for real-time health monitoring. The region's emphasis on personalized and preventive healthcare has accelerated the adoption of biosensors, particularly wearable devices. Europe is also investing in research and development, supported by regulatory frameworks and initiatives like the European Union's Horizon programs. The COVID-19 pandemic has further boosted demand for biosensors in home diagnostics and point-of-care applications. Technological advancements, including nanotechnology and AI, and IoT-enabled medical devices are also driving the market.

For instance, in October 2024, Bruker Corporation has acquired Dynamic Biosensors GmbH, a Munich-based biosensor development company, strengthening its biophysical portfolio for molecular interaction and kinetic analysis. Dynamic Biosensors offers deep insights into inter-molecular and molecule-single cell interactions, supporting drug discovery in pharma, biotech, and basic research.

Competitive Landscape

The major global players in the medical biosensors market include Abbott Laboratories, Bio-Rad Laboratories Inc, Biosensors International Group, Ltd, DuPont Biosensor Materials, Ercon, Inc, Johnson & Johnson, Koninklijke Philips N.V, LifeScan, Inc Medtronic, Molex LLC among others.

Emerging Players

The emerging players in the medical biosensors market include Biolinq, Nemaura Medical, GlySens Incorporated and among others

Key Developments

In August 2024, Metropolis Healthcare Limited has launched two advanced diagnostic laboratories in Telangana, Warangal and Nizamabad, as part of its strategic plan to improve diagnostic services in Tier 2 and Tier 3 cities. The facilities, covering 1,200 sq. ft., can process over 15,000 samples per month and offer a range of tests from basic pathology to advanced molecular diagnostics. By integrating state-of-the-art technology, Metropolis aims to strengthen local healthcare infrastructure and increase access to high-quality diagnostics for residents in these regions.
In October 2024, The Saudi Food and Drug Authority (SFDA) has launched an initiative to develop diagnostic laboratory equipment and advance 3D printing in hospitals. The initiative aims to foster innovation, research, and development while reducing costs for hospitals and medical laboratories. The equipment and reagents are provided for diagnostic and therapeutic use within hospitals and are not intended for commercial purposes. The initiative aligns with the SFDA's commitment to encouraging innovators, supporting national industries, and empowering investors regarding products under its oversight.
In October 2024, The Krishna Institute of Medical Sciences (KIMS) has signed a memorandum of understanding (MoU) with Wipro GE Healthcare to procure medical technology and services worth up to Rs 700 crore. The MoU covers new products, replacements, and sewices for 12 KIMS hospitals and 4 upcoming hospitals over the next three years. The MoU covers a full suite of medical technology products designed by Wipro GE Healthcare.

Why Purchase the Report?

Pipeline & Innovations: Insights into clinical trials, product pipelines, and upcoming advancements.
Market Positioning: Analysis of product performance and growth potential for optimized strategies.
Real-World Evidence: Integration of patient feedback for enhanced product outcomes.
Physician Preferences: Insights into healthcare provider behaviors and adoption strategies.
Regulatory & Market Updates: Coverage of recent regulations, policies, and emerging technologies.
Competitive Insights: Analysis of market share, competitor strategies, and new entrants.
Pricing & Market Access: Review of pricing models, reimbursement trends, and access strategies.
Market Expansion: Strategies for entering new markets and forming partnerships.
Regional Opportunities: Identification of high-growth regions and investment prospects.
Supply Chain Optimization: Assessment of risks and distribution strategies.
Sustainability & Regulation: Focus on eco-friendly practices and regulatory changes.
Post-Market Surveillance: Enhanced safety and access through post-market data.
Value-Based Pricing: Insights into pharmacoeconomics and data-driven R&D decisions.

The global medical biosensors market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
Supply Chain: Distribution and Supply Chain Managers.
Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
Academic & Research: Academic Institutions.

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product Type
3.2. Snippet by Application
3.3. Snippet by Technology
3.4. Snippet by End User
3.5. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Rise in the Technological Advancements
4.2. Restraints
- 4.2.1. Accuracy and Reliability Limitations
4.3. Opportunity
- 4.3.1. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. By Product type

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product type
- 6.1.2. Market Attractiveness Index, By Product type
6.2. Wearable Biosensors*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Non-Wearable Biosensors

7. By Application

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 7.1.2. Market Attractiveness Index, By Application
7.2. Diagnostics*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Monitoring
7.4. Therapeutics
7.5. Patient Monitoring
7.6. Home Care

8. By Technology

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 8.1.2. Market Attractiveness Index, By Technology
8.2. Electrochemical Biosensors*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Optical Biosensors
8.4. Thermal Biosensors
8.5. Piezoelectric Biosensors

9. By End User

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.1.2. Market Attractiveness Index, By End User
9.2. Hospitals and Clinics*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Home Healthcare
9.4. Research Laboratories
9.5. Ambulatory Surgical Centers

10. By Region

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.2.7.1. U.S.
  - 10.2.7.2. Canada
  - 10.2.7.3. Mexico
10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.3.7.1. Germany
  - 10.3.7.2. U.K.
  - 10.3.7.3. France
  - 10.3.7.4. Spain
  - 10.3.7.5. Italy
  - 10.3.7.6. Rest of Europe
10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
- 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.4.7.1. Brazil
  - 10.4.7.2. Argentina
  - 10.4.7.3. Rest of South America
10.5. Asia-Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.5.7.1. China
  - 10.5.7.2. India
  - 10.5.7.3. Japan
  - 10.5.7.4. South Korea
  - 10.5.7.5. Rest of Asia-Pacific
10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
- 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. Company Profiles

12.1. Abbott Laboratories*
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio and Description
- 12.1.3. Financial Overview
- 12.1.4. Key Developments
12.2. Bio-Rad Laboratories Inc
12.3. Biosensors International Group, Ltd
12.4. DuPont Biosensor Materials
12.5. Ercon, Inc
12.6. Johnson & Johnson
12.7. Koninklijke Philips N.V
12.8. LifeScan, Inc
12.9. Medtronic
12.10. Molex LLC (LIST NOT EXHAUSTIVE)

13. Appendix

13.1. About Us and Services
13.2. Contact Us

02-2729-4219

+886-2-2729-4219

License/价格

FAQ

全球医疗生物感测器市场 - 2024-2031

Global Medical biosensors market - 2024-2031

目录

第 1 章：方法与范围

第 2 章：定义与概述

第 3 章：执行摘要

第 4 章：动力学

第 5 章：产业分析

第 6 章：依产品类型

第 7 章：按申请

第 8 章：按技术

第 9 章：最终用户

第 10 章：按地区

第 11 章：竞争格局

第 12 章：公司简介

第 13 章：附录